5-((2-(4-(2-CARBOXYETHYLCARBAMOYL)PHENYLAZO)-4-(2-CARBOXYETHYL-CARBAMOYL)(PHENYLAZO(SALICYLIC ACID)))), (E,E)-
UNII DD3LDH08S8
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-((2-(4-(2-carboxyethylcarbamoyl)phenylazo)-4-(2-carboxyethyl-carbamoyl)(phenylazo(salicylic Acid)))), (e,e)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DD3LDH08S8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1346606-53-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H24N6O9 IBCQZTYNNGNNDJ-HIPRBATPSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-((2-(4-(2-carboxyethylcarbamoyl)phenylazo)-4-(2-carboxyethyl-carbamoyl)(phenylazo(salicylic Acid)))), (e,e)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.